20 Results

People

  1. Usmani
    Usmani
  2. Hashmi
    Hashmi
  3. Lesokhin
    Lesokhin
  4. Landau
    Landau
  5. Mailankody
    Mailankody
  6. Perales
    Perales
  7. Rajeeve
    Rajeeve
  8. Shah
    Shah
  9. Shah
    Shah
  10. Brumwell
    Brumwell

Groups

  1. Department of Medicine (8)
  2. Hematologic Malignancies, Division of (8)
  3. Center for Hematologic Malignancies (7)
  4. Bone Marrow Transplant (5)
  5. Hematologic Malignancies Research (4)
  6. Myeloma (3)
  7. Survivorship Research (3)
  8. CTCR Scholars (2)
  9. GME, Medicine (2)
  10. Graduate Medical Education (2)
  1. "ciltacabtagene autoleucel"
Formats
  1. Journal Article (11)
  2. Review (5)
  3. Editorial (2)
  4. Meeting Abstract (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (8)
  2. Hematologic Malignancies, Division of (8)
  3. Center for Hematologic Malignancies (7)
  4. Bone Marrow Transplant (5)
  5. Hematologic Malignancies Research (4)
  6. Myeloma (3)

More Groups

People
  1. Saad Usmani (5)
  2. Hamza Hashmi (4)
  3. Alexander Lesokhin (3)
  4. Gunjan Shah (2)
  5. Heather Landau (2)
  6. Miguel-Angel Perales (2)

More People

Years
  1. 2025 (2)
  2. 2024 (11)
  3. 2023 (4)
  4. 2022 (2)
  5. 2021 (1)
Publications
  1. Blood (2)
  2. Blood Cancer Journal (2)
  3. Clinical Lymphoma, Myeloma and Leukemia (2)
  4. Frontiers in Oncology (2)
  5. The Lancet Haematology (2)
  6. American Journal of Hematology (1)

More Publications

Publishers
  1. Elsevier Inc. (3)
  2. Frontiers Media S.A. (3)
  3. Nature Publishing Group (3)
  4. American Society of Hematology (2)
  5. Elsevier Science, Inc. (2)
  6. Springer (2)

More Publishers

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Beyond BCMA: The next wave of CAR T cell therapy in multiple myeloma
    Review

    Miller, K.; Hashmi, H.; Rajeeve, S.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Autologous hematopoietic stem cell transplantation for multiple myeloma in the age of CAR T cell therapy
    Review

    Hughes, C. F. M.; Shah, G. L.; Paul, B. A.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save
  • Soluble B-cell maturation antigen in multiple myeloma
    Review

    Costa, B. A.; Ortiz, R. J.; Lesokhin, A. M.; Richter, J.
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Extrapolation of survival data using a Bayesian approach: A case study leveraging external data from cilta-cel therapy in multiple myeloma
    Journal Article

    Palmer, S.; Lin, Y.; Martin, T. G.; Jagannath, S.; Jakubowiak, A.; Usmani, S. Z.; Buyukkaramikli, N.; Phelps, H.; Slowik, R.; Pan, F.; more...
    Oncology and Therapy (2023)

    Fulltext@MSK | Save
  • Patient perceptions regarding ciltacabtagene autoleucel treatment: Qualitative evidence from interviews with patients with relapsed/refractory multiple myeloma in the CARTITUDE-1 study
    Journal Article

    Cohen, A. D.; Hari, P.; Htut, M.; Berdeja, J. G.; Usmani, S. Z.; Madduri, D.; Olyslager, Y.; Goldberg, J. D.; Schecter, J. M.; Jackson, C. C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Driving CARs to new places: Locally produced BCMA CAR T cells to treat multiple myeloma
    Editorial

    Sjöstrand, M.; Sadelain, M.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Noninfectious causes of fever in hematologic malignancies. Are antibiotics still indicated?
    Review

    Shahid, Z.; Epstein, D. J.
    Current Opinion in Infectious Diseases (2023)

    Fulltext@MSK | Save
  • Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): A phase 1b–2, open-label study
    Journal Article

    Martin, T.; Lin, Y.; Agha, M.; Cohen, A. D.; Htut, M.; Stewart, A. K.; Hari, P.; Berdeja, J. G.; Usmani, S. Z.; Yeh, T. M.; more...
    The Lancet Haematology (2022)

    Fulltext@MSK | Save
  • Editorial to the special issue entitled “Imaging in immunooncology”
    Editorial

    Fruhwirth, G. O.; Weigelin, B.; Daldrup-Link, H. E.; Ponomarev, V.
    Molecular Imaging and Biology (2022)

    Fulltext@MSK | Save
  • Incidence, mitigation, and management of neurologic adverse events in the CARTITUDE-2 study of patients with multiple myeloma treated with ciltacabtagene autoleucel (cilta-cel)
    Meeting Abstract

    Jakubowiak, A.; Parekh, S.; Madduri, D.; Santomasso, B.; Perez-Larraya, J. G.; van de Donk, N. W. C. J.; Arnulf, B.; Mateos, M. V.; De Braganca, K. C.; Varsos, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save